MedTrace Logo

Multicenter Study of Chloroprocaine Versus Ropivacaine for Epidural Labor Analgesia

NCT06472232 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 356

Last updated 2024-06-25

No results posted yet for this study

Summary

Women requiring epidural labor analgesia were randomized into two groups, one with the local anesthetic chloroprocaine and the other with ropivacaine. The primary outcome was to observe the analgesic scores of the two groups of drugs as well as adverse reactions.

Conditions

  • Obstetric Labor

Interventions

DRUG

Chloroprocaine

Selection of low concentration of chloroprocaine as local anesthetic for labor analgesia

Sponsors & Collaborators

  • Beijing Obstetrics and Gynecology Hospital

    collaborator OTHER

  • International Peace Maternity and Child Health Hospital

    collaborator OTHER

  • Nanjing Medical University

    collaborator OTHER

  • Anhui Women and Children's Medical Center

    collaborator UNKNOWN

  • Jiaxing Maternity and Child Health Care Hospital

    collaborator OTHER

  • Gansu Maternal and Child Health Center

    collaborator UNKNOWN

  • Urumqi Maternal and Child Health Center

    collaborator UNKNOWN

  • Shengjing Hospital

    collaborator OTHER

  • Zhongnan Hospital

    collaborator OTHER

  • The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University

    collaborator UNKNOWN

  • Second Hospital of Jilin University

    collaborator OTHER

  • Women's Hospital School Of Medicine Zhejiang University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-18
Primary Completion
2025-06-16
Completion
2025-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06472232 on ClinicalTrials.gov